Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1998Journal of the American Oil Chemists Society

Microbial synthesis of chiral intermediates for β‐3‐receptor agonists

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRamesh N. PatelRabindranath Tagore Medical CollegeABAmit BanerjeeIndian Institute of Chemical BiologyLCLinda Chu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Patel et al. (1998) studied this question.

synapsesocial.com/papers/6a7bca10cbabed012ec628aahttps://doi.org/10.1007/s11746-998-0081-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Total synthesis of 1233A1993 · 192 citations
  2. 2Stereochemical control of microbial reduction. 17. A method for controlling the enantioselectivity of reductions with bakers' yeast1991 · 202 citations
  3. 3Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent1992 · 298 citations